[Federal Register Volume 77, Number 85 (Wednesday, May 2, 2012)]
[Notices]
[Pages 26012-26013]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-10513]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Public Meeting of the Presidential Commission for the Study of 
Bioethical Issues

AGENCY: Presidential Commission for the Study of Bioethical Issues, 
Office of the Assistant Secretary for Health, Office of the Secretary, 
Department of Health and Human Services.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Presidential Commission for the Study of Bioethical Issues 
will conduct its ninth meeting in May. At this meeting, the Commission 
will discuss topics related to the ethical issues associated with the 
development of medical countermeasures for children as well as access 
to, and privacy of, human genome sequence data.

DATES: The meeting will take place on Thursday, May 17, 2012, from 9 
a.m. to approximately 5:30 p.m.

ADDRESSES: The Embassy Row Hotel, 2015 Massachusetts Ave. NW., 
Washington, DC 20036. Telephone: (202) 265-1600.

FOR FURTHER INFORMATION CONTACT: Hillary Wicai Viers, Communications 
Director, Presidential Commission for the Study of Bioethical Issues, 
1425 New York Ave. NW., Suite C-100, Washington, DC 20005. Telephone: 
(202) 233-3960. Email: Hillary.Viers@bioethics.gov. Additional 
information may be obtained at www.bioethics.gov.

SUPPLEMENTARY INFORMATION: Pursuant to the Federal Advisory Committee 
Act of 1972, Public Law 92-463, 5 U.S.C. app. 2, notice is hereby given 
of the ninth meeting of the Presidential Commission for the Study of 
Bioethical Issues (the Commission). The meeting will be open to the 
public with attendance limited to available space. The meeting will 
also be webcast at http://www.bioethics.gov.
    Under authority of Executive Order 13521, dated November 24, 2009, 
the President established the Commission. The Commission is an advisory 
panel of the nation's leaders in medicine, science, ethics, religion, 
law, and engineering. The Commission advises the President on 
bioethical issues arising from advances in biomedicine and related 
areas of science and technology. The Commission seeks to identify and 
promote policies and practices that ensure scientific research, health 
care delivery, and technological innovation are conducted in a socially 
and ethically responsible manner.
    The main agenda items for the Commission's ninth meeting are, 
first, to discuss the ethical issues associated with the development of 
medical countermeasures for children, and second, to discuss issues of 
privacy of, and access to, human genome sequence data.
    The draft meeting agenda and other information about the 
Commission, including information about access to the webcast, will be 
available at http://www.bioethics.gov.
    The Commission welcomes input from anyone wishing to provide public 
comment on any issue before it. Respectful debate of opposing views and 
active participation by citizens in public exchange of ideas enhances 
overall public understanding of the issues at hand and conclusions 
reached by the Commission. The Commission is particularly interested in 
receiving comments and questions during the meeting that are responsive 
to specific sessions. Written comments will be accepted at the 
registration desk and comment forms will be provided to members of the 
public in order to write down questions and comments for the Commission 
as they arise. To accommodate as many individuals as possible, the time 
for each question or comment may be limited. If the number of 
individuals wishing to pose a question or make a comment is greater 
than can reasonably be accommodated during the scheduled meeting, the 
Commission may make a random selection.
    Anyone planning to attend the meeting who needs special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should notify Esther Yoo by telephone at (202) 233-
3960, or email at

[[Page 26013]]

Esther.Yoo@bioethics.gov in advance of the meeting. The Commission will 
make every effort to accommodate persons who need special assistance.
    Written comments will also be accepted in advance of the meeting 
and are especially welcome. Please address written comments by email to 
info@bioethics.gov, or by mail to the following address: Public 
Commentary, Presidential Commission for the Study of Bioethical Issues, 
1425 New York Ave. NW., Suite C-100, Washington, DC 20005. Comments 
will be publicly available, including any personally identifiable or 
confidential business information that they contain. Trade secrets 
should not be submitted.

    Dated: April 23, 2012.
Lisa M. Lee,
Executive Director, Presidential Commission for the Study of Bioethical 
Issues.
[FR Doc. 2012-10513 Filed 5-1-12; 8:45 am]
BILLING CODE 4154-06-P